France Services, news and resources from France Tweet Jump to NewsNews in other languagesLibrary resources News Screening and testing policy People with diabetes or high alcohol consumption at higher risk of late hepatitis C diagnosis Keith Alcorn / 24 September 2021 People with diabetes and those with hazardous alcohol intake were significantly more likely to remain undiagnosed with hepatitis C and present with advanced fibrosis, a large number of people diagnosed with hepatitis ... Coronavirus US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Keith Alcorn / 16 August 2021 People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ... Coronavirus Advanced cirrhosis or alcohol use disorder raised the risk of COVID-19 death in France Keith Alcorn / 25 June 2021 People with advanced cirrhosis or alcohol use disorder were significantly more likely to die from COVID-19 in France during 2020 compared to the rest of the population, a study of the French ... Hepatitis C elimination Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline Keith Alcorn / 27 January 2021 Hepatitis C is becoming more concentrated in gay and bisexual men with HIV in France as direct-acting antiviral treatment cures the infection in other people with HIV while hepatitis C transmission between ... Hepatocellular carcinoma (HCC) Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... More news News in other languages Canada: Les lignes directrices canadiennes sur la co-infection VIH-VHC arrivent bientôt CATIE / 17 December 2013 Sofosbuvir: De nouvelles associations interpellent Gilead Seronet / 16 December 2013 France: Percée thérapeutique contre l'hépatite C Le Figaro / 11 December 2013 Gilead Sciences, Inc. : L'agence américaine des médicaments (U.S. Food and Drug Administration) approuve le Sovaldi? (sofosbuvir) de Gilead pour le traitement de l'hépatite C chronique Zone Bourse / 10 December 2013 France: VHB et VHC : Journée nationale des patients le 14 décembre Seronet / 10 December 2013 More Library resources Technical supplement - The new psychoactive products Type.pdf Published19 March 2014 Posted byFédération Addiction How to reduce risks with the new psychoactive substances (NPS) Type.pdf Published19 March 2014 Posted byFédération Addiction Prise de position de la SPILF, l’AFEF, la SFLS et la SNFMI sur l’utilisation des inhibiteurs de protéase de 1ere génération du VHC chez les patients co-infectés par le VIH et le VHC de génotype 1 TypeWeb page Published22 March 2013 AuthorSNSMI, SFLS, AFEF, et SPILF AVIS relatif à la vaccination contre la grippe saisonnière chez les personnes atteintes d’une hépatopathie chronique avec ou sans cirrhose TypeWeb page Published22 February 2013 AuthorHaut Conseil de la santé publique View more resources Do you work for a hepatitis organisation?Add your organisation to the listings > World Hepatitis Alliance policy report on the prevention and control of viral hepatitis Download the report for France To see all of the World Hepatitis Alliance Global Policy Reports, please visit the WHA website. ELPA’s Euro Hepatitis Care Index Download Indicators for France on prevention; screening; access to treatment; national strategy; outcomes. To see all of the European Care Index and compare indicators between counties please visit: www.hep-index.eu/index-map.html.